自动化影像分化用于帕金森综合征鉴别
这项前瞻性多中心队列研究评估了基于3-T扩散MRI与支持向量机学习的自动化影像分化(AIDP)在鉴别帕金森病(PD)、多系统萎缩(MSA)和进行性核上性麻痹(PSP)中的表现。在独立测试集(145例前瞻性患者)中,AIDP对PD vs非典型帕金森综合征、MSA vs PSP、PD vs MSA、PD vs PSP的AUROC分别为0.96、0.98、0.98、0.98;49例尸检脑组织中46例(93.9%)的AIDP预测得到神经病理学证实。研究达到主要终点,结果提示可将AIDP用于常见帕金森综合征的诊断检查。
要点
- AIDP在测试集中鉴别PD vs非典型帕金森综合征的AUROC为0.96(95%CI 0.93-0.99)。
- AIDP鉴别MSA vs PSP、PD vs MSA、PD vs PSP的AUROC均为0.98。
- 49例尸检脑组织中46例(93.9%)AIDP预测得到神经病理学证实。
核心结论
- 这项前瞻性多中心队列研究达到主要终点,结果提示可将AIDP用于常见帕金森综合征的诊断检查。
研究设计与样本
- 前瞻性、多中心队列研究,2021年7月至2024年1月在美国/加拿大21个帕金森研究组站点开展。
- 纳入经既定标准诊断且3名独立盲法运动障碍神经科医生临床诊断一致的PD、MSA和PSP患者。
- 共筛查316例,249例符合纳入标准(平均[SD]年龄67.8[7.7]岁;155例男性[62.2%]),其中PD 99例、MSA 53例、PSP 97例。
- 另纳入 retrospective 队列396例(平均[SD]年龄65.8[8.9]岁;234例男性[59.1%]),其中PD 211例、MSA 98例、PSP 87例。
- 患者分配至训练集(78%;104例前瞻性、396例回顾性)或独立测试集,测试集包括145例(22%;PD 60例、MSA 27例、PSP 58例)前瞻性患者(平均年龄67.4[SD 7.7]岁;95例男性[65.5%])。
主要发现
- 测试集中PD vs非典型帕金森综合征:AUROC 0.96(95%CI 0.93-0.99),PPV 0.91,NPV 0.83。
- 测试集中MSA vs PSP:AUROC 0.98(95%CI 0.96-1.00),PPV 0.98,NPV 0.81。
- 测试集中PD vs MSA:AUROC 0.98(95%CI 0.96-1.00),PPV 0.97,NPV 0.97。
- 测试集中PD vs PSP:AUROC 0.98(95%CI 0.96-1.00),PPV 0.92,NPV 0.98。
- 49例尸检脑组织中46例(93.9%)AIDP预测得到神经病理学证实。
临床怎么用
- 结果提示可将AIDP用于常见帕金森综合征的诊断检查。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Magnetic resonance imaging (MRI) paired with appropriate disease-specific machine learning holds promise for the clinical differentiation of Parkinson disease (PD), multiple system atrophy (MSA) parkinsonian variant, and progressive supranuclear palsy (PSP). A prospective study is needed to test whether the approach meets primary end points to be considered in a diagnostic workup. OBJECTIVE: To assess the discriminative performance of Automated Imaging Differentiation for Parkinsonism (AIDP) using 3-T diffusion MRI and support vector machine (SVM) learning. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective, multicenter cohort study conducted from July 2021 to January 2024 across 21 Parkinson Study Group sites (US/Canada). Included were patients with PD, MSA, and PSP with established criteria and unanimous agreement in the clinical diagnosis among 3 independent, blinded neurologists who specialize in movement disorders. Patients were assigned to a training set or an independent testing set. EXPOSURE: MRI. MAIN OUTCOMES AND MEASURES: Area under the receiver operating characteristic curve (AUROC) in the testing set for primary model end points of PD vs atypical parkinsonism, MSA vs PSP, PD vs MSA, and PD vs PSP. AIDP was also paired with antemortem MRI to test against postmortem neuropathology in a subset of autopsy cases. RESULTS: A total of 316 patients were screened and 249 patients (mean [SD] age, 67.8 [7.7] years; 155 male [62.2%]) met inclusion criteria. Of these patients, 99 had PD, 53 had MSA, and 97 had PSP. A retrospective cohort of 396 patients (mean [SD] age, 65.8 [8.9] years; 234 male [59.1%]) was also included. Of these patients, 211 had PD, 98 had MSA, and 87 had PSP. Patients were assigned to the training set (78%; 104 prospective, 396 retrospective) or independent testing set, which included 145 (22%; 60 PD, 27 MSA, 58 PSP) prospective patients (mean age, 67.4 [SD 7.7] years; 95 male [65.5%]). The model was robust in differentiating PD vs atypical parkinsonism (AUROC, 0.96; 95% CI, 0.93-0.99; positive predictive value [PPV], 0.91; negative predictive value [NPV], 0.83), MSA vs PSP (AUROC, 0.98; 95% CI, 0.96-1.00; PPV, 0.98; NPV, 0.81), PD vs MSA (AUROC, 0.98; 95% CI, 0.96-1.00; PPV, 0.97; NPV, 0.97), and PD vs PSP (AUROC, 0.98; 95% CI, 0.96-1.00; PPV, 0.92; NPV, 0.98). AIDP predictions were confirmed neuropathologically in 46 of 49 brains (93.9%). CONCLUSIONS AND RELEVANCE: This prospective multicenter cohort study of AIDP met its primary end points. Results suggest using AIDP in the diagnostic workup for common parkinsonian syndromes.
引用
- Vaillancourt DE, Barmpoutis A, Wu SS, et al. Automated Imaging Differentiation for Parkinsonism. JAMA Neurol. 2025. PMID: 40094699. doi:10.1001/jamaneurol.2025.0112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。